Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. (Q51230179)

1 April 2018

title

Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. (English)

1 reference

1 April 2018

0 references

1 reference

1 reference

Ingeborg van der Tweel

12

object named as

Ingeborg van der Tweel

1 reference

1 April 2018

Marc J. M. Bonten

14

object named as

Marc J M Bonten

1 reference

1 April 2018

author name string

Mirelle Koeman

1

1 reference

1 April 2018

Andre J A M van der Ven

2

1 reference

1 April 2018

Eelko Hak

3

1 reference

1 April 2018

Hans C A Joore

4

1 reference

1 April 2018

Karin Kaasjager

5

1 reference

1 April 2018

Annemarie G A de Smet

6

1 reference

1 April 2018

Graham Ramsay

7

1 reference

1 April 2018

Tom P J Dormans

8

1 reference

1 April 2018

Leon P H J Aarts

9

1 reference

1 April 2018

Ernst E de Bel

10

1 reference

1 April 2018

Willem N M Hustinx

11

1 reference

1 April 2018

Andy M Hoepelman

13

1 reference

1 April 2018

language of work or name

English

0 references

publication date

7 April 2006

1 reference

1 April 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

1 April 2018

volume

173

1 reference

1 April 2018

issue

12

1 reference

1 April 2018

page(s)

1348-1355

1 reference

1 April 2018

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Comparative susceptibility of hospital isolates of gram-negative bacteria to antiseptics and disinfectants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Nebulizer choice for inhaled colistin treatment in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

A reassessment of the in-vitro activity of colistin sulphomethate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Tables of the number of patients required in clinical trials using the logrank test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Antibacterial activity of chlorhexidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Colistin: an antimicrobial for the 21st century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Prevention of ventilator-associated pneumonia: an evidence-based systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Selective decontamination of digestive tract in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Relationship of microbiologic diagnostic criteria to morbidity and mortality in patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Effect of ventilator-associated pneumonia on mortality and morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

The systemic inflammatory response in the development of ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Effectiveness of topical chlorhexidine powder as an alternative to hexachlorophane for the control of Staphylococcus aureus in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

Oropharyngeal or Gastric Colonization and Nosocomial Pneumonia in Adult Intensive Care Unit Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200505-820OC

10.1164/RCCM.200505-820OC

21 January 2018

Identifiers

DOI

1 reference

1 April 2018

PubMed ID

16603609

1 reference

1 April 2018